Koers IM Cannabis Corp. Canadian Securities Exchange
Aandelen
IMCC
CA44969Q1090
Farmaceutische producten
Omzet 2024 * | 46,3 mln. 33,89 mln. 31,46 mln. | Omzet 2025 * | - | Marktkapitalisatie | 15,94 mln. 11,67 mln. 10,83 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -10 mln. -7,32 mln. -6,79 mln. | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,34 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 64,16% |
Recentste transcriptie over IM Cannabis Corp.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Oren Shuster
CEO | Chief Executive Officer | 55 | 11-10-19 |
Uri Birenberg
DFI | Director of Finance/CFO | 49 | 10-10-23 |
- | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | 22-02-21 | |
Marc Lustig
CHM | Chairman | 51 | 11-10-19 |
Oren Shuster
CEO | Chief Executive Officer | 55 | 11-10-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,02% | 4,17 mld. | |
+143,65% | 2,33 mld. | |
+138,10% | 78,45 mln. |